Dual guide CRISPR hybrid DNA/RNA polynucleotides and methods of use
Inventors
May, Andrew Paul • Donohoue, Paul Daniel
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present disclosure provides DNA-guided CRISPR systems; polynucleotides comprising DNA, RNA and mixtures thereof for use with CRISPR systems; and methods of use involving such polynucleotides and DNA-guided CRISPR systems.
Core Innovation
The invention provides a set of two Class 2 Type II CRISPR polynucleotides forming a dual guide polynucleotide. The first polynucleotide comprises an RNA targeting region and an adjacent activating region, while the second polynucleotide comprises a complementary activating region, a nexus, and at least one downstream hairpin. Together, the activating regions hybridize to form a bulged RNA/DNA activating duplex region capable of binding with a Cas9 protein.
The system encompasses mixed RNA/DNA dual-guide and single-guide CRISPR designs, including Type V Cpf1 configurations and Type II Cas9-mediated genome editing. Functional editing activity is established in human cells and in maize embryos at the liguleless 1 and Ms45 loci. The DNA-containing guide polynucleotides provide target cleavage with reduced off-target cleavage relative to RNA guides, while offering increased stability and economical synthesis.
Claims Coverage
The claim coverage identifies one independent claim with three inventive features directed to the dual guide Class 2 Type II CRISPR polynucleotide.
Bulged RNA/DNA activating duplex region
The first polynucleotide comprises an RNA targeting region adjacent to an activating region, and the second polynucleotide comprises an activating region complementary to the first, hybridizing to form a bulged activating duplex comprising a mixture of RNA and DNA.
Nexus and downstream hairpin
The second Class 2 Type II CRISPR polynucleotide further comprises a nexus 3′ to the activating region and at least one hairpin 3′ to the nexus.
Cas9-binding capability
The bulged RNA/DNA activating duplex region is configured to bind with a Cas9 protein.
The independent claim centers on complementary activating regions that form a bulged RNA/DNA duplex capable of binding Cas9, together with a nexus and at least one downstream hairpin on the second polynucleotide.
Stated Advantages
Reduced off-target cleavage relative to RNA guides is reported.
DNA-containing guides are described as more stable and economical to synthesize.
Documented Applications
Type II Cas9-mediated maize genome editing, with mutations reported at the maize liguleless 1 and Ms45 loci.
Genome editing activity in human cells.
Interested in licensing this patent?